DIETHYLENE GLYCOL MONOETHYL ETHER First draft prepared by Dr R. Walker University of Surrey United Kingdom 1. EXPLANATION This substance was previously reviewed at the twentieth meeting of the Committee (Annex 1, references 41, 42) but no ADI was allocated because of inadequacies in the toxicological data. In particular, the lack of metabolic and reproduction/teratogenicity studies was noted, and the carcinogenicity studies did not meet current standards. At its present meeting, the Committee reviewed new data on metabolism and excretion in humans, together with studies on reproduction and teratogenicity in mice and rats, and a number of genotoxicity studies that were generally negative. It was also aware of a number of other studies on pharmacological activity and irritancy. Since the last review, additional data have become available and are summarized and discussed in the following monograph. The previously published monograph has been expanded and is incorporated into this monograph. 2. BIOLOGICAL DATA 2.1 Biochemical Aspects 2.1.1 Absorption In an in vitro system for assessing percutaneous absorption using human epidermal membranes, the "donor" chambers contained undiluted diethylene glycol monoethyl ether (> 98% pure) and diffusion was monitored at 30 min intervals for 8 h using GC. The absorption rate was 0.21 ± 0.15 mg/cm2/h. Measurement of tritiated water transfer before and after exposure to the test compound indicated that there were slight irreversible changes in barrier function during exposure to the test compound (Dugard et al., 1984). 2.1.2 Metabolism and pharmacokinetics Diethylene glycol monoethyl ether administered orally or subcutaneously in doses of 3-5ml/kg bw to rabbits produced an increased urinary excretion of glucuronic acid. The increase could account for only 0.8-2.3% of the dose administered, the major part of the dose being oxidized (Fellows et al., 1947). The quantitative urinary excretion of diethylene glycol monoethyl ether was investigated in the rabbit after oral, intravenous, subcutaneous and percutaneous administration. After oral dosing of two animals at a level of 5 ml/kg bw, both animals died during the first day and total excretion was only 0.8% and 0.33%. After intravenous administration to 15 rabbits at dose levels of 0.5-3.4 ml/kg most of the dose was excreted during the first day (for 13/15 rabbits), the percentage excreted tending to increase with dose. After a single parenteral dose of 1.0-3.0 ml/kg, urinary excretion was monitored for up to 4 consecutive days. Excretion was high in the first 24 h and the total percentage of the dose excreted in urine increased with dose. After repeated daily parenteral doses of 0.16, 0.32 or 0.63 ml/kg bw, total urinary excretion increased with dose and equalled 4.7, 5.0 and 11.6%, respectively. Groups of 2-3 rabbits received daily applications of 0.08 to 2.5 ml/kg bw to a clipped area of skin for up to 30 days. Total urinary excretion was small and variable (1.3-9.4%); there was no correlation between percentage excretion and period of application over the period 9-30 days. Blood samples were collected for up to 2.5 h after administration of diethylene glycol monoethyl ether intravenously to rabbits at doses of 1.0-3.0 ml/kg bw. Clearance was rapid with less than half of the dose detectable within 5 min and only small/trace amounts present in blood after 30 min. When a single dose of diethylene glycol monoethyl ether (11.2 mmol) was given to an adult human volunteer (sex and age not specified) about 68% of the dose was excreted in the urine as (2-ethoxyethoxy)acetic acid within 12 h (Kamerling et al., 1977; Miller, 1987). 2.2 Toxicological studies 2.2.1 Acute toxicity Species Route LD50 Reference (ml/kg/bw) Mouse oral 6.6 Laug et al., 1939 oral 12.5 Latven & Molitor, 1939 oral 8.0 Berte et al., 1986 s.c. 2.5-6.0 Hanzlik et al., 1947a s.c. 5.5 Latven & Molitor, 1939 i.v. .. Latven & Molitor, 1939 4.3 Latven & Molitor, 1939 i.v. 3.9 Stenger et al., 1971 i.p. <2.0 Latven & Molitor, 1939 i.p. 3.9 Karel et al., 1947 i.p. 2.3 Budden et al., 1979 i.p. 5.4 Berte et al., 1986 Rat oral 8.0 Berte et al., 1986 oral 5.5-9.7 Hanzlik et al., 1947a oral 5.3-5.7 Laug et al., 1939 oral 7.3-10.4 Smyth et al., 1941 oral 6.3 Weil, 1972 s.c. 6.0 Hanzlik et al., 1947a s.c. 3.4 Stenger et al., 1971 i.v. >4.0-<5.0 Stenger et al., 1971 i.v. 2.2 Budden et al., 1978 i.v. 2.9 Stenger et al., 1971 i.p. 5.4 Berte et al., 1986 i.p. 3.0 Sanderson, 1959 Species Route LD50 Reference (ml/kg/bw) Guinea-pig oral 3.7-5.0 Laug et al., 1939 oral 3.1-4.3 Smyth et al., 1941 Rabbit i.v. 2.5 Smyth et al., 1941 i.v. 0.9 Stenger et al., 1971 s.c. 2.0 Stenger et al., 1971 p.c. 8.5 Hanzlik et al., 1947a p.c. 10.3 Carpenter, 1947 Cat s.c. 1.0-2.0 Lehmann & Flury, 1943 i.v. 4.2 Laug et al., 1939 i.v. 1.0 Budden et al., 1978 Dog i.v. 3.0 Smyth et al., 1941 i.v. 1.0 Budden et al., 1978 No abnormalities were obvious below a dosage level of 1 ml/kg bw by any route. Ataxia with initially increased and later decreased respiratory rate occurred with 2-2.5 ml/kg bw while higher dosage levels led to central nervous depression and coma followed by recovery or death. Delayed deaths were associated with renal glomerular and tubular degeneration. 2.2.2 Short-term studies 2.2.2.1 Mice Groups of 20 male and 20 female mice were fed on diets containing 0, 0.2, 0.6, 1.8 or 5.4% diethylene glycol monoethyl ether for 90 days. The test material contained less than 0.4% ethylene glycol. Six males of the 5.4% group died between the 5th-12th weeks with signs of advanced renal damage (hydropic degeneration). The growth rate was reduced and anaemia was found in males at the highest dose level. Serum transaminase and urea levels were unaffected by treatment. The relative kidney weight was increased in both sexes receiving the 5.4% diet and in males fed on the 1.8% diet. In females receiving the highest dosage level, the relative heart and liver weights were greater than in controls. Centrilobular hepatocyte enlargement was found at the 5.4 and 1.8% dietary levels. Renal tubular cell enlargement with nuclear pyknosis occurred in animals at the 5.4% dietary level. Areas of proximal tubular degeneration and atrophy were seen in all groups, including controls, but they appeared with greater frequency at the top feeding level. No oxalate crystals were seen in the kidneys or bladder. The no-effect level was 0.6%, equivalent to an intake of 850-1000 mg/kg bw/day (Gaunt et al., 1968). In a pilot study to determine the MTD for a subsequent reproduction study, groups of 10 female CD1 mice were given daily doses of diethylene glycol monoethylether by gavage for 8 consecutive days. No necropsies were performed. The MTD was reported to be 5500 mg/kg bw (Piccirillo et al., 1983). In a pilot study to determine the MTD for a subsequent reproduction study, groups of 8 male and 8 female mice, 8 weeks of age were given 0.0, 1.0, 2.0, 3.0, 4.0, or 5% diethylene glycol monoethyl ether (> 99% pure) in drinking water for 14 days. During the exposure period, one male in the top dose group exhibited dehydration on days 8-10 and tremors prior to death on day 11. The weight gain was reduced significantly in the 4.0% and 5.0% dose groups. No necropsies were performed. The MTD was estimated to be 2.5% in drinking water (NTP 1984). 2.2.2.2 Rats Groups of 5 male and 5 female rats were given pure diethylene glycol monoethyl ether in drinking water at doses of 0.21-3.88 g/kg bw for thirty days. The maximum No Adverse Effect Level was reported to be 0.49 g/kg bw. In a similar experiment using carbitol solvent containing ethylene glycol, the NOEL was less than the lowest dose tested, 0.41 g/kg (Smyth & Carpenter, 1948). Groups of 12 male and 12 female rats were fed for 90 days on diets containing 0, 0.25, 1.0 or 5.0% diethylene glycol monoethyl ether contaminated by 0.64% ethylene glycol. The condition and health of the animals remained generally good but 1 male on the 5% diet died after 23 days following a period of weight loss. No abnormalities were found on haematological examination. Urinary glutamic oxaloacetic transaminase activity was significantly increased and the relative kidney weight raised in both sexes and the relative testes weight raised in males of the 5% group. Renal tubular dilatation with inflammatory cell infiltration was present in all groups, including controls, but was accentuated in the 5% group. Hydropic degeneration was seen in 2 males and 1 female and slight to moderate fatty infiltration in most animals was also found in this group. The no-effect level was 1% in the diet, equivalent to 800 mg/kg bw/day (Hall et al., 1966). Groups of 15 male and 15 female rats were fed on diets containing 0, 0.5 or 5.0% diethylene glycol monoethylether (containing less than 0.4% ethylene glycol) for 90 days. No animals died. The growth rate and food intake were reduced and slight anaemia was seen in females after 6 weeks and in males at the end of the study at the highest dosage level. Serum urea and transaminase levels were unaffected by treatment. The relative weight of kidneys was increased in the 5% group and cells of the proximal tubular cells were grossly enlarged with pyknotic nucleii. No oxalate crystals were found in the kidneys or bladder. The no-effect level was 0.5% in the diet, equivalent to 250 mg/kg bw/day (Gaunt et al., 1968). Groups of male and female rats were given daily s.c. doses of diethylene glycol monoethyl ether of 100, 200, 400 or 800 µl/kg bw/day for 4 weeks. No deaths were reported but doses of 200-400 µl/kg bw/day caused dyspnoea, somnolence and mild ataxia, with some growth retardation in females; 800 µl/kg bw/day also caused growth retardation in males. Pathological changes in the liver, kidney and testes were also seen at doses of 200 µl/kg bw/day (Stenger et al., 1971). 2.2.2.3 Rabbits Technical diethylene glycol monoethyl ether (containing 30% ethylene glycol) was applied daily to the clipped abdominal skin of adult rabbits for up to 30 days. The animals were then observed for a further 30 days after which they were sacrificed for histological examination. The mortality varied from 57-65% and histological examination revealed marked hydropic degeneration of renal tubular epithelial cells (Hanzlik et al., 1947c) Tests of renal function (phenol red clearance and blood urea) were carried out on 18 males and hepatic function (rose Bengal) in 6 males exposed as above to daily doses of 0.02 to 1.5 ml/kg bw. Renal function was impaired in 83.3% of the animals (15/18) and hepatic function reduced in 88.3% (5/6) animals. Similar function tests applied to animals dosed parenterally at daily doses of 0.16 to 0.63 ml/kg bw until death confirmed decreased renal function but hepatic function was not impaired (Hanzlik et al., 1947d). 2.2.2.4 Ferrets Groups of 2 or 3 male ferrets were fed on diet providing 0, 0.5, 1.0, 2.0 or 3.0 ml diethylene glycol monoethyl ether/kg bw/day for 9 months. The sample of solvent contained less than 0.4% ethylene glycol. The body weights of the two highest dosage levels tended to be lower than those of controls and their food intake was also diminished. No abnormal constituents were found in urine. The water intake of all treatment groups was greater than controls during the period of measurement (first seven weeks). The concentrating power of the kidney was decreased consistently at the two highest dosage levels. However at necropsy organ weights were not changed by treatment and no abnormal gross or histopathological abnormalities were detected. The no-effect level was 0.5 ml/kg bw (Butterworth et al., 1975). 2.2.2.5 Pigs Groups of 3 male and 3 female pigs were given diethylene glycol monoethyl ether in their diet for 90 days. Initially the daily intake was 0, 167, 500 or 1500 mg/kg bw/day but the top dose was reduced to 1000 mg/kg bw/day after 3 weeks since 2 animals had to be killed in extremis after 2 and another after 3 weeks. These pigs became lethargic and comatose and autopsy showed subcutaneous and pulmonary oedema and pleural and peritoneal effusions. The livers were of a yellowish colour and they were enlarged, the cut surfaces showing a pale cortex with petechial and medullary congestion. Calculi were found in the urinary tract. Proteinuria with casts also occurred. Serum urea was elevated to above 100 mg% and histological examination showed hydropic degeneration and tubular desquamation with glomerular atrophy. Livers showed extensive hydropic degeneration. There was slight anaemia in males receiving 1000 mg/kg bw/day for the full 90 days and more severe anaemia in those that died. Serum urea and transaminase levels were normal in all animals killed at the end of the investigation. The kidney weight was elevated in animals receiving the highest dose level. Hepatocytes of centrilobular and midzonal areas were grossly enlarged with pyknotic nuclei, and fatty infiltration occurred at the top dosage level and in one female receiving 500 mg/kg diet. Most of the renal cortex was affected by extensive areas of tubular hydropic degeneration at the highest dose level but this was less marked at the 500 mg/kg level. Other changes at the 1000 mg/kg level were consistent with uraemia resulting from renal failure. No oxalate crystals were seen in the kidneys or bladder. The no-effect level was 167 mg/kg bw/day (Gaunt et al., 1968). 2.2.3 Long-term/carcinogenicity studies 2.2.3.1 Mice Groups of 10 male and 10 female mice were fed on control diet or diet containing 5% diethylene glycol monoethyl ether (purity: less than 0.2% ethylene glycol). This provided males with 7.5 and females with 6.0 ml/kg bw/day. The body weights were reduced in males between the 2nd and 6th months but were similar to controls at other times. Body weight was continuously lower than controls in females. Approximately 40% of test and control females were alive at 12 months while males survived longer, the last test male at 18 months and control at 21 months approximately. Only one of 30 animals receiving diethylene glycol monoethyl ether (pure or containing 1% ethylene glycol) showed hydropic degenerative changes in the kidney (Hanzlik et al., 1947b). 2.2.3.2 Rats A group of 8 female and 12 male rats was fed on a diet containing 2.16% diethylene glycol monoethyl ether for up to 2 years. A similar group of litter mates received control diet. Food and water were offered ad lib. No significant decrease in growth rate occurred in the test group and the mortality rate was unaffected; however, the number of animals surviving for 2 years was not stated. Only animals surviving the longest received full pathological examination but the number examined was not stated. In the test group there was an increased incidence of testicular atrophy with interstitial oedema, centrilobular or diffuse atrophy of the liver with bile duct proliferation and fatty degeneration, and an oxalate stone was found in the kidney of one animal (Morris et al., 1942). A group of 10 male and 5 female rats were given diethylene glycol monoethyl ether (purity: less than 0.2% ethylene glycol) as a 1% solution in drinking water. Thirteen male and 8 female control rats received untreated water; both received diet and drinking fluid ad libitum. The intake of the diethylene glycol monoethyl ether was approximately 1.3 ml/kg bw/day in male and 1.5 ml/kg bw/day in female animals. No significant differences were found in growth rate or in food or fluid intakes. After approximately 12 months, 8 test and 4 control animals remained alive. No gross or microscopic abnormalities were found in the small number of animals examined (Hanzlik et al., 1947b). Groups of 8 male and 8 female Wistar rats received drinking water incorporating diethylene glycol monoethyl ether containing either 29.5% ethylene glycol or less than 0.2% ethylene glycol. Groups received the equivalent of 0, 10, 40, 190 or 950 mg of the purer substance/kg bw/day for up to 757 days. Feed and drinking fluids were available ad libitum. Animals were allowed to produce offspring to form a first generation, and a second generation was produced from these. However, the length of the period of treatment of the offspring was not reported. The lifespan of animals receiving 950 mg of the mixture/kg bw/day was significantly shortened compared with controls but other groups were unaffected. Growth was reduced compared with controls in animals of the parent generation receiving 950 and 190 mg mixture/kg bw/day or 920 mg purer diethylene glycol monoethyl ether/kg bw/day but the effect on growth in other groups and other generations was probably not of significance. No adverse effects were found on haematological examination, and blood urea and glucose and serum proteins were unaffected by the treatments. No increase in oxalic or oxaluric acids were found in the urine of test animals, although the urine protein concentration was raised in the 950 mg and 920 mg/kg bw groups. The tumours found were typical of elderly rats and the overall incidence (4.4%) was similar to other reported figures for the strain of rat. However, the report does not allow a full assessment of the incidence and types of tumours in each group. Bladder calculi were found only in animals receiving the highest dosage level of the mixture. Only the liver and kidney were examined microscopically in all animals but a few more organs were examined in others. Epithelial necrosis of the renal tubules and cloudy swelling of hepatic tissue were the only adverse effects which could be attributed to treatment and these were seen in animals receiving 950, 190 and 40 mg mixture/kg bw/day and 920 mg purer diethylene glycol monoethyl ether/kg bw/day. The no adverse effect level for diethylene glycol monoethyl ether containing less than 0.2% ethylene glycol was 200 mg/kg bw/day (Smyth et al., 1944, 1964). 2.2.4 Reproduction studies 2.2.4.1 Mice In a reproduction study, CD1 mice, 11 weeks of age at commencement, were given diethylene glycol monoethyl ether in drinking water at concentrations of 0, 0.25, 1.25 or 2.5%. Animals of each sex (F0 generation) were exposed for a premating period of 7 days, then throughout a 98-day cohabitation period, followed by a further 21 day segregation. Animals from the last litter produced by the control and 2.5% groups were weaned and two male and two female animals selected from each of 10 litters (F1 generation). The F1 animals were caged in groups of two or three by sex and received the same drinking fluid as the parental groups for 74 ± 10 days. A male and female from different litters within treatment groups were then cohabited for one week, the pairs then separated and the females allowed to produce their litters. Continuous exposure of the F0 generation to diethylene glycol monoethyl ether in drinking water from 11 weeks of age had no effect on the number of pairs able to produce at least one litter, number of litters per pair, live pups per litter, proportion of pups born alive nor sex ratios. At the highest (2.5%) concentration, the mean live pup weights were significantly reduced (P <0.05) relative to controls. Deaths among the parent groups during the study were not treatment-related. In the F1 generation the body weights of males and females were slightly depressed relative to controls at birth, weaning and at the start of the mating period. Continuous exposure of this generation to diethylene glycol monoethyl ether in utero, via mother's milk, and subsequently at 2.5% in drinking water, had no significant effects on mating behaviour, fertility rate, number of live pups per litter, proportion of pups born alive, sex ratio or live pup weight. At terminal necropsy, sperm assessment indicated no significant differences in sperm concentration nor percentage of abnormal sperm in the cauda epididymis between treated and control males, but the percentage motile sperm was significantly reduced in treated animals. Body weights were not affected by treatment but the relative liver weight was significantly increased and relative brain weight significantly decreased. The authors concluded that diethylene glycol monoethyl ether was not a reproductive toxicant under the conditions of this study in either F0 or F1 breeding pairs (NTP, 1984; Williams et al., 1990). Groups of 50 pregnant CD-1 mice were given diethylene glycol monoethyl ether (>99% pure) by gavage in aqueous solution at the MTD on days 7-14 of gestation. Maternal body weights were recorded on days 7 and 18 of gestation and day 3 postpartum. Reproductive indices reported included pup survival in utero, pup perinatal and postnatal (2.5d) survival and pup body weights. The dose of 5500 mg/kg bw caused 14% maternal mortality and reduced body weight in maternal survivors, and slightly reduced mean pup birth weight but did not affect reproduction indices (97% viable litters and 98% postnatal survival) (Schuler et al., 1984; Piccirillo et al., 1983). 2.2.5 Special studies on teratogenicity 2.2.5.1 Drosophila melanogaster In a teratology screen using Drosophila melanogaster diethylene glycol monoethyl ether was incorporated into medium at the MTD. The eggs were deposited on the medium and the insects exposed throughout incubation, larval stage and pupa formation. The emergent adult insects were examined for external morphological anomalies. At a concentration of 7.5 ml/kg medium, developmental effects were observed in the form of an irregular shaped abdomen in 7.7% of the treated insects; the abnormality was rare in the control insects (Schuler et al., 1982). In a similar study, no morphological abnormalities were observed at the same concentration of 7.5 ml/kg in the medium (Schuler et al., 1983). 2.2.5.2 Rats Groups of 15 pregnant Sprague-Dawley rats were exposed to diethylene glycol monoethyl ether by inhalation of the vapour at an aerial concentration of 100 ppm for 7 h/day on days 7-15 of gestation. The dams were sacrificed on day 20 and 2/3 of the fetuses examined for visceral defects by Wilson's technique and 1/3 for skeletal defects by Staples technique. At this level of exposure, diethylene glycol monoethyl ether was not maternally toxic and no teratogenic or embryotoxic effects were observed (Nelson et al., 1982, 1984). Diethylene glycol monoethyl ether was applied to the shaved interscapular skin of pregnant Sprague-Dawley rats four times daily on days 7-16 of gestation in doses of 0.35 ml at 2.5 h intervals. The dams were killed on day 21 and the fetuses weighed and examined for external malformations. Half of the fetuses were examined for visceral abnormalities and half for skeletal malformations. There was no evidence of teratogenicity or fetotoxicity although maternal body weight was significantly lower than controls (Hardin, 1983; Hardin et al., 1984). 2.2.6 Special studies on genotoxicity Test system Test object Concentration Results Reference of DEGMEE Ames test S.typhimurium 0-1 ml/plate Negative Berte et al., (1) TA97, (1986) TA100, TA102 Negative TA1535, TA1537 Weak pos. Berte et al., TA1538 Weak pos. (1986) Yeast gene Saccharomyces 1% & 10% Negative Berte et al., mutation cerevisiae D7 (1986) Micro-nucleus Mice CD-1 2 x 2 ml/kg bw Negative Berte et al., test (1986) (1) With and without beta-naphthoflavone-induced mouse liver S9 fraction. 2.2.7 Special studies on cytotoxicity In a test to evaluate cytotoxicity against a human hepatoma cell line in vitro as an alternative to the Draize eye irritation test, diethylene glycol monoethyl ether was added to the incubation medium for 24 h at 37 °C. No effects were observed at the maximum tolerated concentration of 0.2% (15 mM) (Stark et al., 1983). In similar studies using human hepatoma cell line HepG2, diethylene glycol monoethyl ether caused an inhibition of 3H-uridine uptake and the UI50 was estimated to be 191mM (Dierickx & Martens, 1986; Jacobs et al., 1988). In further studies of uridine uptake using murine BALB/c 3T3 cells, the UI50 was found to be 129 mM (Shopsis & Sathe, 1984). 2.2.8 Special studies on haematology Three adult rabbits were given intramuscular doses of diethylene glycol monoethyl ether of 0.62, 0.82 or 1.6 ml/kg bw daily for 2 weeks and haematological examinations performed. No effects were noted on haemoglobin, RBC, total leucocytes, platelets or reticulocytes. Similarly, no effects on these parameters were seen in three pigeons dosed i.m. at daily doses of 1 ml/kg bw (Hanzlik et al., 1947b) 2.2.9 Special studies on irritancy The inflammatory action of diethylene glycol monoethyl ether was tested by instillation of one drop of pure material into the rabbit eye. Slight hyperaemia of the conjunctiva was reported (von Oettingen & Jirouch, 1931). In a similar test in the rabbit the degree of irritation was scored on a three point scale (+,++,+++). The effects were graded as oedema + and hyperaemia ++ (Latven & Molitor, 1939). Ocular irritancy was assessed on solutions of commercial diethylene glycol monoethyl ether containing ethylene glycol at various concentrations in 0.85% aqueous NaCl solutions. Solutions of 8%, 10% and 12% of the commercial preparation caused inflammation of the mucous membrane persisting for 5, 10 and 30 mins respectively. Solutions of 20% caused discomfort (blinking), 25% caused pain (eye rubbing) and 30% resulted in inflammation that persisted for 60 mins. No other adverse effects on the eye were reported (Cranch et al., 1942). Ocular effects in similar studies using water, propylene glycol or Deobase as vehicle were graded maximally at point 2 on a 10 point scale of injury (Carpenter & Smyth, 1946) while no evidence of ocular effects was seen when a 10 µl drop of diethylene glycol monoethyl ether was applied to the cornea of guinea-pigs (Sanderson, 1959). The ocular irritation index (OII) was determined in the rabbit after application of diethylene glycol monoethyl ether, undiluted or as aqueous solutions, according to official French methods. A 10% solution was graded as non-irritating (acute OII 1.67) while the undiluted material caused slight to moderate irritation (acute OII 16.0) (Guillot et al., 1982). Diethylene glycol monoethyl ether was tested for ocular irritancy in rabbits using objective quantitative procedures involving determination of dry tissue as an index of corneal and conjunctival oedema and dye diffusion (Evans blue) as a measure of vascular leakage in the conjunctivae and aqueous humour. Diethylene glycol monoethyl ether was applied to the eye, undiluted or as a solution in distilled water, 1, 3, 6, 7 or 13 times over 2, 4, 7, 26 and 50 h, respectively. A 25% solution produced significant increases in vascular leakage in the conjunctivae and aqueous humour while, in addition to these effects, 100% diethylene glycol monoethyl ether caused significant conjunctival and corneal oedema (Laillier et al., 1976). Diethylene glycol monoethyl ether was without effect in ocular irritancy tests in the rabbit conducted according to EEC and OECD guidelines (Jacobs et al., 1988). Dermal irritancy was assessed by the trypan blue capillary permeability method after exposure of depilated rabbit skin to patches soaked in technical carbitol (ca 30% ethylene glycol) for 2 h daily for 2-6 days. There was no evidence of dermal irritation using this technique (Hanzlik et al., 1947c). Similarly, the cutaneous primary irritation index (PII) in patch tests on diethylene glycol monoethyl ether according to official French protocols was 0.29 (non-irritant). Determination of the cumulative cutaneous irritation index by official French methods involving cutaneous exposure daily for six weeks showed a 10% solution to be non-irritant (mean maximum irritation index 0.13) while undiluted material was slightly irritant but well tolerated (MMII 1.13) (Guillot et al., 1982). Commercial diethylene glycol monoethyl ether containing ethylene glycol caused no irritation per se when applied to rabbit skin for 24 h (Ogiso et al., 1988). Irritation was assessed after injection of 0.1 ml diethylene glycol monoethyl ether intradermally into shaved guinea-pig abdominal skin. The test compound was graded as moderately irritant in this test. No irritant effects were observed in a 24 h patch test on shaved, intact abdominal skin of rabbits (Latven & Molitor, 1939). Conversely, in an occluded patch test on abraded rabbit skin, irritant effects were reported with a primary irritation index of 0.5 (Draize et al., 1944). Wads of cotton saturated with 50% or 70% aqueous solutions of commercial grade diethylene glycol monoethyl ether were applied to depilated skin of rabbits, wounded by crossed cuts into the cutis and replaced daily until healing was complete. No adverse effects on healing were reported and scar formation was complete in 4-6 days. In similar tests in which major wounds were made by excising the epidermal and dermal layers and laying bare the underlying muscle, 50% carbitol had no significant effect on the healing time relative to controls (mean 11.5 days); healing was somewhat prolonged with 70% carbitol (19.5 days) (Cranch et al., 1942). 2.2.10 Special studies on pharmacological activity When 1 ml of a 25% aqueous, solution of diethylene glycol monoethyl ether was injected into the lymph sac of frogs weighing about 30 g, moderate central depression resulted. Diethylene glycol monoethyl ether had no effect on reflex excitability as assessed by the Turck method in the frog, but muscle response time to a minimal effective faradic stimulation of the nerve trunk in frog nerve-muscle preparations was slightly depressed (von Oettingen & Jirouch, 1931). A lack of effect on reflex reaction time in the frog by immersion of the leg was reported by Latven & Molitor (1939). Diethylene glycol monoethyl ether had a slight depressive action on rabbit ileum smooth muscle contraction using the Magnus protocol (von Oettingen & Jirouch, 1931) and in later studies the EC50 was found to be 1.21% ± 0.45% in Ringer's solution (Muir, 1983). Diethylene glycol monoethyl ether caused a marked depression and arrest of cardiac activity in perfused frog heart. Dilutions of 1-4% had no effect on peripheral blood vessels in the Trendelenberg frog perfusion method but i.v. injection of a 50% solution to lightly anaesthetised rabbits caused a fall in blood pressure (von Oettingen & Jirouch, 1931). In a CNS-profile test, 3 NMRI male mice were dosed i.p. with increasing doses of diethylene glycol monoethyl ether. The minimum symptomatic dose was 5.0 g/kg bw at which there was ptosis, piloerection, hypothermia, muscle relaxation, inhibition of Haffner reflex and cyanosis. The material was classified as a neuroleptic. The ED50 in the inclined screen test was also found to be 5.0 g/kg bw (Budden et al., 1979). In the rotating rod test on four NMRI male mice, diethylene glycol monoethyl ether was given in increasing doses i.p. and the time to dropping off measured at intervals after injection. The minimal effective dose was 300 mg/kg bw. In a balance rod test the ED50 was found to be 3.1 g/kg bw (Budden et al., 1979). Diethylene glycol monoethyl ether potentiated the hexobarbitone sleeping time in female NMR1 mice. The ED50s for a doubling or quadrupling of the sleeping time were 0.7 (0.43-1.21) g/kg bw and 2.4 (1.37-4.25) g/kg bw respectively (Budden et al., 1979). 2.3 Observations in humans 2.3.1 Acute intoxication A 44-year old man ingested diethylene glycol monoethyl ether at doses of about 2 ml/kg bw. Kidney function was affected but there was no oliguria and only slight uraemia. Effects on nervous and respiratory functions were also reported (Brennaas, 1960). 2.3.2 Special studies on skin irritation and sensitization Commercial grade diethylene glycol monoethyl ether was rubbed on the inner wrist surface for 5 mins daily on 10 consecutive days. Irritant effects were noted with 3/60 subjects showing congestion or papules, mainly originating at hair follicles and persisting for several hours (Cranch et al., 1942). No irritant effects were evident in 48 h closed patch test on 5 male volunteers diethylene glycol monoethyl ether was applied at a concentration of 20% in petrolatum (Kligman, 1972). Patch tests were conducted on undiluted commercial grade diethylene glycol monoethyl ether (containing 30% ethylene glycol) in 99 subjects using 48 h exposure with subsequent examination at intervals up to 1 month. Slight positive reactions (faint erythema persisting for 48 h after removal) occurred in 24/99 subjects. Similar tests on aqueous dilutions of pure diethylene glycol monoethyl ether (0.2% ethylene glycol) or carbitol solvent were carried out on 31 subjects. No reactions were seen with 5% solutions of either material and a concentration-related increasing frequency of reactions (faint erythema) was seen at higher concentrations. Undiluted materials led to 14 reactions with the carbitol solvent and 5 reactions with the pure material (Meininger, 1948). In 48-h closed patch tests on 50% solutions of diethylene glycol monoethyl ether, 44% of volunteers showed erythema, oedema or vesicles, 18% definite erythema and 34% questionable erythema (Motoyoshi, et al., 1984). Patch tests were conducted on commercial grade diethylene glycol monoethyl ether in 98 subjects using an initial contact period of 7 days, followed by 10 days withdrawal then a further 3 day test period. Definite reactions were reported in 7/98 persons but a standardized scoring method was not used (Cranch, Smyth & Carpenter, 1942). Repeat patch tests using undiluted commercial grade diethylene glycol monoethyl ether (30% ethylene glycol) were carried out on 45 subjects 4 weeks after initial tests. After a second exposure of 48 h, examinations were carried out at intervals up to 1 month. Positive reactions (faint erythema restricted to test area) occurred in 15 subjects (Meininger, 1948). 3. COMMENTS AND EVALUATION The Committee was informed that the use of diethylene glycol monoethyl ether as a carrier solvent for flavours could lead to carry-over levels as high as 1000 mg/kg in foods as consumed, but no data on potential daily intakes were available. In these circumstances, the principles previously developed for materials occurring in foods in small amounts (Annex 1, reference 76) were not applicable. Although the metabolism, reproduction and teratogenicity, and genotoxicity studies met some of the requirements of the Committee, information on chronic toxicity/carcinogenicity was still inadequate. In view of the apparent potential for relatively high exposure to this substance, the Committee was unable to allocate an ADI because of the lack of such information. In order to re-evaluate diethylene glycol monoethyl ether the Committee would require either: (a) adequate data indicating that human intakes are sufficiently low for the principles applicable to materials occurring in foods in small amounts to apply: or (b) the results of an adequate carcinogenicity/chronic study in rats and mice. The Committee considered that, in the light of the data reviewed at the present meeting, the 6-month study in pigs requested at its twentieth meeting would not be needed for a re-evaluation. 4. REFERENCES BERTE, F., BIANCHI,A., GREGOTTI, C., BIANCHI, L. & TATEO, F. (1986) In vivo and in vitro toxicity of carbitol. Bol. Chim. Farm., 125: 401-403 BRENNAAS, O. (1960) Forgiftning med dietylenglykolmonoetyleter [A case of intoxication due to diethylene glycol monethyl ether]. Nord. Med., 64: 1219-1293. BUDDEN, R., KUHL, U.G. & BUSCHMANN, G. (1978). Studies on the pharmacodynamic activity of several drug solvents (1st communication: Diethylene-glycol monoethyl ether, N,N-diethylacetamide, dimethylsulfoxide. Drug Res., 28(2): 1571-1579. BUDDEN, R., KUHL, U.G. & BAHLSEN, J. (1979). Experiments on the toxic sedative and muscle relaxant potency of various drug solvents in mice. Pharmac. Ther., 5: 467-474. BUTTERWORTH, K.R., GAUNT, I.F. & GRASSO, P. (1975) A nine-month toxicity study of diethylene glycol monoethyl ether in the ferret. Unpublished report by the British Industrial Biological Research Association. Submitted to WHO. CARPENTER, C.P. (1947) Cellosolve acetate. J. Am. Med. Ass., 135: 880. CARPENTER, C.P. & SMYTH, H.F. (1946). Chemical burns of the rabbit cornea. Am. J. Opthalmology, 29: 1363-1372. COSMETIC INGREDIENT REVIEW (1985). Final report on the safety assessment of butylene glycol, hexylene glycol, ethoxydiglycol, and dipropylene glycol. J. Am. Col. Toxicol., 4: 223-248. CRANCH, A.G., SMYTH, H.F. & CARPENTER, C.P. (1942). External contact with monoethyl ether of diethylene glycol (carbitol solvent). Archs. Derm. Syph., 45: 553-559. DIERICKX, P.J. & MARTENS, M. (1986). Validation of the uridine uptake inhibition assay in cultured human hepatoma cells. Belg. Arch. Soc. Gen. Hyg., 44: 470-477. DRAIZE, J.H. WOODARD, G. & CALVERY, H.O. (1944). Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J. Pharmac. exp. Ther., 82 (2): 377-390. DUGARD, P.H., WALKER, M., MAWDSLEY S.J. & SCOTT, R.C. (1984). Absorption of some glycol ethers through human skin in vitro. Envir. Hlth. Perspect., 57: 193-197. FELLOWS, J.K., LUDUENA, F.P. & HANZLIK, P.J. (1947) Glucuronic acid excretion after diethylene glycol monoethyl ether (carbitol) and some other glycols. J. Pharmacol., 89: 210-213. GAUNT, I.F., COLLEY, J., GRASSO, P., LANSDOWN, A.B.G. & GANGOLLI, S.D. (1968) Short-term toxicity of diethylene glycol monoethylether in the rat, mouse and pig. Fd. Cosmet. Toxicol., 6: 689-705. GRUNDSCHOBER, F. (1991) Personal communication to the FAO (Dr J. Weatherwax). GUILLOT, J.P., MARTINI, M.C., GIAUFFRET, J.Y., GONNET, J.F. & GUYOT, J.Y. (1982). Safety evaluation of some humectants and moisturizers used in cosmetic formulations. Int. J. Cosmetic Sc., 4: 67-79 HALL, D.E., LEE, F.S., AUSTIN, P. & FAIRWEATHER, F.A. (1966) Short-term feeding study with diethylene glycol monoethyl ether in rats. Fd Cosmet. Toxicol., 4: 263-268. HANZLIK, P.J., LUDUENA, F.P., LAWRENCE W.S. & HANZLIK, H. (1947a) Acute toxicity and general systemic actions of diethylene glycol monoethyl ether (carbitol). J. Ind. Hyg. Toxicol., 29: 190-195. HANZLIK,P.J., LAWRENCE, W.S. & LAQUEUR, G.L. (1947b) Comparative chronic toxicity of diethylene glycol monoethyl ether (carbitol) and some related glycols: results of continued drinking and feeding. J. Ind. Hyg. Toxicol., 29: 233-241. HANZLIK, P.J., LAWRENCE, W.S., FELLOWS, J.K., LUDUENA, F.P. & LAQUEUR, G.L. (1947c). Epidermal application of diethylene-glycol monoethyl ether (carbitol) and some other glycols. J. Ind. Hyg. Toxicol., 29: 325-341. HANZLIK, P.J., LUDUENA, F.P., LAWRENCE, W.S., FELLOWS, J.K. ET AL. (1947d). Toxicity, excretion and fate of diethylene glycol monoethyl ether compared with other glycols applied epidermally. Fed. Proc., 6: 336. HARDIN, B.D. (1983). Reproductive toxicity of the glycol ethers. Toxicology, 27: 91-102. HARDIN, B.D., GOAD, P.T. & BURG, J.R. (1984). Developmental toxicity of four glycol ethers applied cutaneously to rats. Environ. Hlth. Perspectives, 57: 69-74. JACOBS, G.A. DIERICKX, P.J. & MARTENS, M.A. (1988). Evaluation of the in vitro uridine uptake inhibition assay in comparison with the in vivo eye irritation test as prescribed by the EEC. Altern. Lab. Anim., 15(4): 290-296. KAMERLING,J.P., DURAN, M., BRUINVIS, L., KETTING, D., WADMAN,S.K., DE GROOT, C.J. & HOMMES, F.A. (1977) (2-ethoxyethoxy) acetic acid: an unusual compound found in the gas chromatographic analysis of urinary organic acids. Clin. Chim. Acta., 77: 397-405. KAREL, L., LANDING, B.H., & HARVEY, T.S. (1947). The intraperitoneal toxicity of some glycols, glycol ethers, glycol esters, and phthalates in mice. Fed. Proc., 6: 342. KLIGMAN, A.M. (1972). Report to RIFM. 25 August 1972. LAILLIER, J., PLAZONNET, B. & LE DOUAREC, J.C. (1976). Evaluation of ocular irritation in the rabbit: development of an objective method of studying eye irritation. The Pred. Chron. Tox. Sh. Term Studies. LATVEN, A.R. & MOLITOR, H. (1939) Comparison of the toxic, hypnotic and irritating properties of eight organic solvents. J. Pharmac. exp. Ther., 65: 89-94. LAUG, E.P., CALVERY, H.O., MORRIS,H.J. & WOODARD, G. (1939) The toxicology of some glycols and derivatives. J. Ind. Hyg. Toxicol., 21: 173. LEHMANN, K.B. & FLURY, F. (1943) Toxicology and hygiene of industrial solvents. Williams & Wilkins: Baltimore, p.378. LUDUENA, F.P., LAWRENCE, W.S., FELLOWS, J.K., CLARK, W.H. & HANZLIK, P.J. (1947). Excretion and fate of diethylene glycol monoethyl ether (carbitol) after epidermal and other methods of administration. Archs. Int. Pharmacodyn., LXXV (1): 1-17. MEININGER, W.M. (1948). External use of "carbitol solvent", "carbitol" and other agents. Archs. Derm. and Syph., 58: 19-26. MILLER, R.R. (1987). Metabolism and disposition of glycol ethers. Drug Metab. Rev., 18(1): 1-22. MORRIS, H.J., NELSON, A.A. & CALVERY, H.O. (1942) Observations on the chronic toxicities of propylene glycol, ethylene glycol, diethylene glycol, ethylene glycol monoethyl ether and diethylene glycol monoethyl ether. J. Pharmacol., 74: 266-273. MOTOYOSHI, K., NOZAWA, S., YOSHIMURA, M. & MATSUDA, K. (1984). The safety of propylene glycol and other humectants. Cosm. & Toilet., 99(10): 83-91. MUIR, C.K. (1983). The toxic effect of some industrial chemicals on rabbit ileum in vitro compared with eye irritancy in vivo. Toxicology Letts., 19: 309-312. NTP (1984). (National Toxicology Program). Diethylene glycol mono-ethyl ether: reproduction and fertility assessment in CD-1 mice when administered in the drinking water. NTP-84-406; PB85-137123. NELSON, B.K., SETZER, J.V., BRIGHTWELL, W.S., MATHINOS, P.R., KUCZUK, M.H. & WEAVER, T.E. (1982). Comparative inhalation teratogenicity of four industrial glycol ether solvents in rats. Teratology, 25(2): 64A. NELSON, B.K., SETZER, J.V. BRIGHTWELL, W.S., MATHINOS, P.R., KUCZUK, M.H. & WEAVER, T.E. (1984). Comparative inhalation teratogenicity of four glycol ether solvents and an amino derivative in rats. Envirn. Hlth Perspect., 57: 261-271. OGISO, T., ITO, Y., IWAKI, M. & ATAGO, H. (1988). Anti-inflammatory activity of ointments of indomethacin and its calcium salt applied to abdominal skin of rat. Chem. Pharm. Bull., 36(2): 757-762. PICCIRILLO, V.J., McCALL, D.L., LUNCHICK, C., PLANKENHORN, L.J., & SEXSMITH, C. (1983). Screening of priority chemicals for reproductive hazards. NIOSH No. 210-81-6010. SANDERSON, D.M. (1959). A note on glycerol formal as a solvent in toxicity testing. J. Pharm. Pha., 11(3): 150-156. SCHULER, R.L., HARDIN, B.,D., & NIEMEIER, R.W. (1982). Drosophila as a tool for the rapid assessment of chemicals for teratogenicity. Tera. Carcin. & Muta., 2: 293-301. SCHULER, R.L., HARDIN, B.D. & NIEMEIER, R.W. (1983). Investigation of Drosophila for teratogenic screening. In: Safety Eval. & Reg. of Chems., 270-276. SCHULER, R.L., HARDIN, B.D., NIEMEIER, R.W., BOOTH, G., HAZELDEN, K.,PICCIRILLO, V. & SMITH K. (1984). Results of testing fifteen glycol ethers in a short-term in vivo reproductive toxicity assay. Envir. Hlth. Perspect., 57: 141-146. SHOPSIS, C. & SATHE, S. (1984). Uridine uptake inhibition as a cytotoxicity test: correlations with the Draize test. Toxicology: 29: 195-206. SMYTH, H.F. & CARPENTER, C.P. (1948). Further experience with the range-finding test in the industrial toxicology laboratory. J. Ind. Hyg. & Toxicol., 30(1): 63-68. SMYTH, H.F., CARPENTER, C.P. & BOYD SHAFFER, C. (1964). Summary of toxicological data: A 2-year study of diethylene glycol monoethyl ether in rats. Fd. Chem. Toxic., 2: 641-642. SMYTH, H.F., CARPENTER, C.P. & SHAFFER, C.B. (1944) Two-year oral doses of carbitol to rats. Unpublished report No. 7-31 by the Mellon Institute of Industrial Research. Submitted to WHO. SMYTH Jr. H.F., SEATON, J. & FISCHER, L. (1941). The single dose toxicity of some glycols and derivatives. J. Ind. Hyg. Toxicol., 23(6): 259-268. STARK, D.M., SHOPIS, C., BORENFREUND, E. & WALBERG, J. (1983). Alternative approaches to the Draize assay: Chemotaxis, cytology, differentiation, and membrane transport studies. In: Product Safety Evaluation, 181-203. STENGER, E.-G., AEPPLI, LISLOTT, MÜLLER, D., PEHEIM, E. & THOMANN, P. (1971) Zur toxikologie des Äthyleneglykol-Monoäthyläthers. Arzneimittel-Forsch., 21: 880. VON OETTINGEN, W.F. & JIROUCH, E.A. (1931). The pharmacology of ethylene glycol and some of its derivatives in relation to their chemical constitution and physical chemical properties. J. Pharmac. exp. Ther., 42: (3), 355-372. WEIL, C.S. (1972). Statistics vs. safety factors and scientific judgement in the evaluation of safety for man. Toxicol. Appl. Pharmacol., 21: 454-463. WILLIAMS, J., REEL, J.R., GEORGE, J.D. & LAMB, J.C. (1990) Reproductive effects of diethylene glycol and diethylene glycol monoethylether in Swiss CD-1 mice assessed by a continuous breeding protocol. Fundament. Appl. Toxicol., 14: 622-635.
See Also: Toxicological Abbreviations Diethylene glycol monoethyl ether (ICSC) Diethylene glycol monoethyl ether (WHO Food Additives Series 10) DIETHYLENE GLYCOL MONOETHYL ETHER (JECFA Evaluation)